Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Maria E. Lozada, Roongruedee Chaiteerakij, Lewis Rowland Roberts

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Treatment of liver and biliary tract cancer is most effective for early and localized disease. Effective screening methods for hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) will lead to early detection and treatment, and thus improvement in survival. Patients at risk of developing HCC and CCA will benefit the most from effective surveillance strategies. In this review, we provide an update on the current status of HCC and CCA surveillance and describe the recent efforts on biomarker development.

Original languageEnglish (US)
Article numberA004
Pages (from-to)128-138
Number of pages11
JournalCurrent Hepatitis Reports
Volume14
Issue number2
DOIs
StatePublished - Jun 1 2015

Keywords

  • Bile duct cancer
  • Diagnosis
  • Early detection
  • Liver cancer
  • Surveillance

ASJC Scopus subject areas

  • Hepatology
  • Virology

Fingerprint Dive into the research topics of 'Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?'. Together they form a unique fingerprint.

  • Cite this